Partners & Cooperations

Partners & Cooperations

PRSG is cooperating with several partners all over the world. Hereafter we present our cooperation partners:

Net-Translators is one of the leading medical translation companies providing translations in over 60 languages. For over 15 years, we’ve translated product-related content for regulators, customer-facing content for medical companies, and medical device manufacturers, and certified medical translations using our meticulous, quality-centered methodology. Our expertise in medical requirements enables us to help our customers navigate the requirements for each country. Net-Translators is certified to ISO 9001:2015, ISO 13485:2016 and ISO 17100:2015. Learn more about Net-Translators by visiting .


EuDRAcon provides expert knowledge and support across a wide range of Regulatory Affairs services since 2007. This is achieved through a pan-European network of independent service providers in regulatory affairs specialised in the field of medicinal products, medical devices, cosmetics and food supplements.

In order to achieve the most effective resolution of all regulatory matters, we have chosen to conduct business in a network of nationally based companies in almost all of the member states of the European Union plus Norway, Switzerland and Lichtenstein. The local presence of service providers eases the communication with regulatory authorities, aids follow-up as well as ensures the reliable management of national steps. This means that we offer quality, flexibility and cost-effectiveness across all of the services we provide for the different markets.

The Research Center Pharmaceutical Engineering (RCPE) is Austria’s leading research center for pharmaceutical process and product design. With our work we support our partners to develop and pioneer novel drugs and associated production routes.

RD&C Research, Development & Consulting GmbH is a globally acting expert office (“Ingenieurbüro”) for pharmaceutical and biotech projects based in Vienna.

Our main expertise comprises

  • Impurity and degradation profiling (expert statements, stability issues, degradation pathways, solid state degradation, stability by design, in silico mutagenicity assessments)
  • Regulatory documentation (expert statements, gap analyses, APIMF, Environmental Risk Assessment, GMP audits, Due Diligences)
  • Management of pharmaceutical development projects (drug discovery and development, MedChem, IP strategies, project management)